Cicaprost
Alternative Names: Cicaprost clathrate; ZK 96480; ZK 97959Latest Information Update: 25 Sep 2000
At a glance
- Originator Bayer Schering Pharma
- Developer Bayer HealthCare Pharmaceuticals; Bayer Schering Pharma
- Class Antiplatelets; Prostaglandins; Small molecules
- Mechanism of Action Epoprostenol agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer metastases
- Discontinued Ischaemic heart disorders; Thrombosis
Most Recent Events
- 25 Sep 2000 No-Development-Reported for Cancer metastases in USA (Unknown route)
- 02 Oct 1997 Discontinued-II for Ischaemic heart disorders in Germany (PO)
- 02 Oct 1997 Discontinued-II for Thrombosis in Germany (PO)